honokiol has been researched along with Cancer of Prostate in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arbiser, JL; Bonner, MY; Hahm, ER; Karlsson, AI; Singh, SV | 1 |
| Hahm, ER; Sakao, K; Singh, SV | 1 |
| Hahm, ER; Singh, KB; Singh, SV | 1 |
| Arbiser, JL; Chung, LW; Fujisawa, M; Gotoh, A; Johnstone, PA; Shigemura, K; Sun, SY; Weksler, B; Zayzafoon, M; Zhau, HE | 1 |
| Hahm, ER; Singh, SV | 1 |
| Arlotti, JA; Hahm, ER; Marynowski, SW; Singh, SV | 1 |
6 other study(ies) available for honokiol and Cancer of Prostate
| Article | Year |
|---|---|
Honokiol inhibits androgen receptor activity in prostate cancer cells.
Topics: Apoptosis; Biphenyl Compounds; Cell Line, Tumor; Cell Survival; Down-Regulation; Humans; Lignans; Male; Prostatic Neoplasms; Receptors, Androgen; Signal Transduction | 2014 |
Honokiol activates reactive oxygen species-mediated cytoprotective autophagy in human prostate cancer cells.
Topics: Animals; Autophagy; Biphenyl Compounds; Cell Line, Tumor; Cytoprotection; Drugs, Chinese Herbal; Humans; Lignans; Male; Mice; Mice, Transgenic; Prostatic Neoplasms; Reactive Oxygen Species | 2014 |
c-Myc is a novel target of cell cycle arrest by honokiol in prostate cancer cells.
Topics: Biphenyl Compounds; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Lignans; Male; Phosphorylation; Prostatic Neoplasms; Proto-Oncogene Proteins c-myc; Receptors, Androgen; RNA, Messenger | 2016 |
Honokiol, a natural plant product, inhibits the bone metastatic growth of human prostate cancer cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biphenyl Compounds; Blotting, Western; Bone Marrow Cells; Bone Neoplasms; Caspases; Cell Proliferation; Docetaxel; Drugs, Chinese Herbal; Flow Cytometry; Humans; Immunoenzyme Techniques; Lignans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Prostate-Specific Antigen; Prostatic Neoplasms; Radiography; Taxoids; Tumor Cells, Cultured | 2007 |
Honokiol causes G0-G1 phase cell cycle arrest in human prostate cancer cells in association with suppression of retinoblastoma protein level/phosphorylation and inhibition of E2F1 transcriptional activity.
Topics: Acetylcysteine; Antineoplastic Agents, Phytogenic; Antioxidants; Biphenyl Compounds; Cell Cycle; Cell Cycle Proteins; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Drugs, Chinese Herbal; E2F1 Transcription Factor; G1 Phase; Humans; Immunoprecipitation; Lignans; Luciferases; Male; Phosphorylation; Prostatic Neoplasms; Reactive Oxygen Species; Resting Phase, Cell Cycle; Retinoblastoma Protein; RNA, Small Interfering; Transcription, Genetic; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2007 |
Honokiol, a constituent of oriental medicinal herb magnolia officinalis, inhibits growth of PC-3 xenografts in vivo in association with apoptosis induction.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2 Homologous Antagonist-Killer Protein; bcl-2-Associated X Protein; bcl-Associated Death Protein; bcl-X Protein; Biphenyl Compounds; Cell Line, Tumor; Humans; Immunoblotting; Lignans; Magnolia; Male; Mice; Mice, Nude; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Proteins; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2 | 2008 |